Compass Capital Management Inc. Purchases 143,767 Shares of CVS Health Co. (NYSE:CVS)

Compass Capital Management Inc. increased its holdings in shares of CVS Health Co. (NYSE:CVS) by 19.9% during the second quarter, Holdings Channel.com reports. The fund owned 867,999 shares of the pharmacy operator’s stock after purchasing an additional 143,767 shares during the quarter. CVS Health accounts for about 3.4% of Compass Capital Management Inc.’s holdings, making the stock its 25th biggest position. Compass Capital Management Inc.’s holdings in CVS Health were worth $51,264,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. USA Financial Formulas grew its position in CVS Health by 573.2% during the fourth quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock worth $30,000 after buying an additional 321 shares in the last quarter. Ables Iannone Moore & Associates Inc. acquired a new stake in shares of CVS Health during the 4th quarter worth $32,000. First Community Trust NA increased its position in shares of CVS Health by 116.2% in the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after purchasing an additional 302 shares during the period. Creekmur Asset Management LLC acquired a new position in CVS Health in the fourth quarter valued at about $34,000. Finally, Steph & Co. grew its stake in CVS Health by 192.0% during the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after buying an additional 288 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Ratings Changes

Several analysts recently issued reports on the stock. SVB Leerink reiterated a “market perform” rating and set a $60.00 price target (down previously from $87.00) on shares of CVS Health in a research report on Wednesday, May 1st. JPMorgan Chase & Co. lowered their price target on CVS Health from $101.00 to $86.00 and set an “overweight” rating for the company in a report on Thursday, May 30th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $62.00 price objective on shares of CVS Health in a research note on Monday, August 19th. Truist Financial reissued a “buy” rating and issued a $66.00 target price (down previously from $90.00) on shares of CVS Health in a report on Thursday, May 2nd. Finally, Bank of America dropped their price objective on shares of CVS Health from $95.00 to $77.00 and set a “buy” rating for the company in a research note on Thursday, May 2nd. Eleven analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and an average target price of $73.24.

CVS Health Trading Up 1.7 %

CVS Health stock traded up $1.01 during trading hours on Friday, reaching $58.75. 9,614,381 shares of the company’s stock were exchanged, compared to its average volume of 11,289,169. The firm has a market capitalization of $73.75 billion, a PE ratio of 10.33, a PEG ratio of 0.57 and a beta of 0.52. The company has a quick ratio of 0.61, a current ratio of 0.81 and a debt-to-equity ratio of 0.78. The firm’s 50 day simple moving average is $58.86 and its 200 day simple moving average is $65.09. CVS Health Co. has a twelve month low of $52.77 and a twelve month high of $83.25.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, topping analysts’ consensus estimates of $1.73 by $0.10. The business had revenue of $91.23 billion during the quarter, compared to the consensus estimate of $91.41 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The firm’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same period in the previous year, the company posted $2.21 earnings per share. Research analysts predict that CVS Health Co. will post 7 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, August 1st. Shareholders of record on Monday, July 22nd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.53%. The ex-dividend date was Monday, July 22nd. CVS Health’s dividend payout ratio (DPR) is currently 46.75%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.